Nexus Pharmaceuticals announces launch of new injection

Lincolnshire-based Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL multiple-dose vials. It is an AP-rated generic to Quelicin.

Related posts